Literature DB >> 25749421

A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.

Gang Xue1, Zhenxin Ren2, Yaxiong Chen2, Jiayun Zhu2, Yarong Du2, Dong Pan1, Xiaoman Li1, Burong Hu3.   

Abstract

It is believed that epigenetic modification plays roles in cancer initiation and progression. Both microRNA and DNA methyltransferase are epigenetic regulation factors. It was found that miR-145 upregulates while DNMT3b downregulates in PC3 cells. Presence of any negative correlationship and their response to irradiation were investigated in the current study. We found that miR-145 downregulated DNMT3b expression by directly targeting the 3'-UTR of DNMT3b mRNA and knockdown of DNMT3b increased expression of miR-145 via CpG island promoter hypomethylation, suggesting that there is a crucial crosstalk between miR-145 and DNMT3b via a double-negative feedback loop. Responses of the miR-145 and DNMT3b to irradiation are a negative correlation. We also found that either overexpression of miR-145 or knockdown of DNMT3b sensitized prostate cancer cells to X-ray radiation. Our findings enrich the complex relationships between miRNA and DNMTs in carcinogenesis and irradiation stress. It also sheds light on the potential combination of ionizing radiation and epigenetic regulation in prostate cancer therapy.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  DNMT3b; Feedback loop; Prostate cancer; Radiosensitivity; miR-145

Mesh:

Substances:

Year:  2015        PMID: 25749421     DOI: 10.1016/j.canlet.2015.02.046

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

Review 1.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

2.  Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145.

Authors:  Hongzhi Lu; Yu He; Lin Lin; Zhengqin Qi; Li Ma; Li Li; Ying Su
Journal:  Tumour Biol       Date:  2015-08-27

3.  Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.

Authors:  G Liang; Y Zhu; A Jing; J Wang; F Hu; W Feng; Z Xiao; B Chen
Journal:  Gene Ther       Date:  2016-08-02       Impact factor: 5.250

4.  Preeclampsia is associated with hypermethylation of IGF-1 promoter mediated by DNMT1.

Authors:  Min Ma; Qiong-Jie Zhou; Yu Xiong; Bin Li; Xiao-Tian Li
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 5.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

6.  BMP2 promotes the differentiation of neural stem cells into dopaminergic neurons in vitro via miR-145-mediated upregulation of Nurr1 expression.

Authors:  Wang Yan; Zhao-Ying Chen; Jia-Qi Chen; Hui-Min Chen
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

7.  microRNAs and Prostate Cancer.

Authors:  Sajni Josson; Leland W K Chung; Murali Gururajan
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 8.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

9.  A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation.

Authors:  Hiroaki Fujimori; Akira Sato; Sota Kikuhara; Junhui Wang; Takahisa Hirai; Yuka Sasaki; Yasufumi Murakami; Ryuichi Okayasu; Mitsuko Masutani
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

10.  Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation.

Authors:  Wei Zhou; Dongdong Tian; Jun He; Yimei Wang; Lijun Zhang; Lan Cui; Li Jia; Li Zhang; Lizhong Li; Yulei Shu; Shouzhong Yu; Jun Zhao; Xiaoyan Yuan; Shuangqing Peng
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.